Quantcast

Latest Merck Stories

2014-07-30 08:33:01

Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo...

2014-07-30 08:32:55

- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to...

2014-07-30 08:25:08

- Reduces risk of sample contamination associated with filtration and membrane transfer BILLERICA, Mass., July 30, 2014 /PRNewswire/ -- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, has launched the EZ-Fit(TM) Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing. The system is more efficient than traditional methods, resulting in increased reliability and streamlined workflows. The unit, which conforms to international standards...

2014-07-30 08:25:06

- Reduces risk of sample contamination associated with filtration and membrane transfer BILLERICA, Mass., July 30, 2014 /PRNewswire/ -- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, has launched the EZ-Fit(TM) Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing. The system is faster and more efficient than traditional methods, resulting in increased reliability and streamlined workflows. The unit, which conforms to international...

2014-07-29 04:22:01

ROCKLAND, Massachusetts, July 29, 2014 /PRNewswire/ -- - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC) - mMCC is a rare and aggressive skin cancer lacking effective treatments - MSB0010718C is also currently being explored in a seven cohort Phase I clinical trial for the treatment of solid...

2014-07-17 08:29:34

"Speaking Up" is Vital, Given the Significant Impact of the Disease on Women WHITEHOUSE STATION, N.J., July 17, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Maria Davis - a music industry promoter and HIV advocate - and Positive Women's Network - USA (PWN-USA) - are joining its national HIV education campaign, I Design. The awareness campaign will help inspire and motivate women living with HIV to "vocalize" how they...

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with...

2014-07-08 12:28:30

GAITHERSBURG, Md., July 8, 2014 /PRNewswire/ -- Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has received an Issue Notification from United States Patent and Trademark Office (USPTO) for a patent entitled "Multi-Targeted RNAi Therapeutics for Scarless Wound Healing of Skin" (US 8,735,567 B2, PCT/US2008/012498). This USPTO issuance, combined with a similar success for a Chinese patent (ZL 200880124132.8) provides a solid foundation and protection for the...

2014-07-01 08:31:08

- Investment reflects company's ongoing commitment to innovation in fertility research ROCKLAND, Mass., July 1, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced its strong support of the Grant for Fertility Innovation (GFI) fund with grants totaling up to EUR 2 million for the years 2014/2015. The announcement was made during the 30(th) annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) currently taking...

2014-06-26 08:28:04

Merkerson Visits Washington, D.C. on June 26 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J., June 26, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and actress S. Epatha Merkerson are bringing the America's Diabetes Challenge: Get to Your Goals program to Washington, D.C. to encourage African Americans with type 2 diabetes to know their A1C -- their average blood sugar level over the past two to three...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related